Patents
Patents for A61K 51 - Preparations containing radioactive substances for use in therapy or testing in vivo (24,291)
01/2007
01/17/2007EP1743174A2 Multimodality nanostructures, methods of fabrication thereof, and methods of use thereof
01/17/2007EP1742966A2 Antibodies and molecules derived therefrom that bind to steap-1 proteins
01/17/2007EP1742926A1 Macrocycle-substituted trimer halogen-benzol derivatives
01/17/2007EP1742898A1 Metal complexes based on tetrathiol ligands and their use in nuclear medical diagnostics and endoradionuclide therapy and method for producing said metal complexes
01/17/2007EP1742670A1 Radium target and method for producing it
01/17/2007EP1742669A1 Compositions and methods for enhancing contrast in imaging
01/17/2007EP1301539B1 Antigen-binding fragments specific for dendritic cells, compositions and methods of use thereof antigens recognized thereby and cells obtained thereby
01/17/2007EP1272160B1 Lipid-based drug delivery systems for topical application
01/17/2007EP0762901B9 TECHNETIUM-99m LABELED PEPTIDES FOR IMAGING
01/17/2007CN1897980A 改进的胃泌素释放肽化合物 Improved gastrin-releasing peptide compounds
01/17/2007CN1897979A Gas-filled microvesicle assembly for contrast imaging
01/17/2007CN1897978A Assembly of gas-filled microvesicle with active component for contrast imaging
01/17/2007CN1895660A Treatment of tumors by administration of growth hormone releasing compounds and their antagonists
01/16/2007US7164016 Complex containing radioactive material; medical diagnosis of tumor
01/16/2007US7163935 Scorpionate-like pendant macrocyclic ligands, complexes and compositions thereof, and methods of using same
01/16/2007US7163671 Stable protein formulation containing tryptophan or a tryptophan derivative or a salt thereof as a stabilizer; storage stability of hematopoietic factors such as erythropoietin
01/16/2007CA2253453C Alkylaminobenzothiazole and -benzoxazole derivatives
01/11/2007WO2007005935A2 Norepinephrine transporter radiotracers and methods of syntheses thereof
01/11/2007WO2007005622A2 System and method for assessing individual healthfulness and for providing health-enhancing behavioral advice and promoting adherence thereto
01/11/2007WO2007005604A2 Polynucleotides encoding isoprenoid modifying enzymes and methods of use thereof
01/11/2007WO2007005491A1 Hydrazide conjugates as imaging agents
01/11/2007WO2007004715A1 Method and composition to individualize levodopa/carbidopa therapy using a breath test
01/11/2007WO2007003944A2 Compounds for imaging and therapy
01/11/2007WO2006078987A3 Laser activated nanothermolysis of cells
01/11/2007US20070009519 Immunoregulatory Antibodies and Uses Thereof
01/11/2007US20070009442 Macrocyclic metal complexes and their use for the production of conjugates with biomolecules
01/11/2007US20070009437 Intracellular trapping of radionuclides by enzyme-mediated reduction
01/11/2007US20070009436 Radionuclide nanoparticles encased by inorganic shell having vector biomolecules attached thereto
01/11/2007US20070009435 Compositions and methods for enhanced delivery to target sites
01/11/2007US20070009434 Imaging and therapeutic method using monocytes
01/11/2007US20070009433 14094, a novel human trypsin family member and uses thereof
01/11/2007US20070009432 Boat tropanes
01/11/2007US20070009431 Solution and method for supporting imaging on a patient
01/11/2007US20070009430 forming inhalable isotope compound such as technetium for use in patient medical diagnosis by electrolytic loading of carbon crucible with isotope, sublimating any isotope carrier in crucible, ablating isotope in crucible, forming an ablation aerosol, delivering aerosol for immediate use by patient
01/11/2007US20070009429 Radiation resistant silicone formulations and medical devices formed of same
01/11/2007US20070009428 Compounds and methods for enhanced delivery to disease targets
01/11/2007US20070009427 Compounds and methods for enhanced delivery to disease targets
01/11/2007DE10225932B4 Bildgebendes Verfahren und Vorrichtung zu dessen Durchführung Imaging method and device for its implementation
01/11/2007DE102005031920A1 Vorrichtung und Verfahren zur Herstellung einer geringen Menge einer radioaktiven Substanzverbindung Apparatus and method for producing a small amount of a radioactive substance combination
01/11/2007CA2848662A1 Il-12/p40 binding proteins
01/11/2007CA2623794A1 Use of dtbz for imaging endocrine pancreas and beta cell mass in type 1 diabetes
01/11/2007CA2614181A1 An integrated approach for generating multidomain protein therapeutics
01/11/2007CA2613469A1 Polynucleotides encoding isoprenoid modifying enzymes and methods of use thereof
01/11/2007CA2613439A1 Hydrazide conjugates as imaging agents
01/11/2007CA2538192A1 Improved process for the production of a radioactive aerosol
01/10/2007EP1741450A1 Composition for medical use having improved water-solubility of peptide and metal-labeling efficiency and preparation for medical use comprising metal-labeled peptide
01/10/2007EP1740946A2 Human monoclonal antibodies against cd20
01/10/2007EP1740225A2 Contrast agents for myocardial perfusion imaging
01/10/2007EP1740224A2 Compositions as adjuvants to improve immune responses to vaccines and methods of use
01/10/2007EP1305051A4 Targeted delivery of cytotoxic drugs a) to activated lymphocytes in patients with transplanted organs, b) as radiosensitizers to cancer cells in patients undergoing radiation therapy, and c) in vitamin-binding proteins as drug carriers in the diagnosis and treatment of cancer
01/10/2007EP1206288B1 Targeted fiberless radiative effectors
01/09/2007US7160537 Preparation of [18F]-fluoro-3'-deoxy-3'-L-fluorothymidine by fluorinating a Boc-protected 3'-deoxythymidine substituted in the 3' position with a leaving group and removing the amine protecting group
01/09/2007US7160536 Radiolabelled metal transport proteins as imaging agents
01/09/2007US7160535 Cardiovascular disorders; antiischemic agents; complex of antioxidant and organometallic compound
01/09/2007CA2295177C Drug targeting system, method of its preparation and its use
01/09/2007CA2270391C Ex-corpore method for treating human blood cells
01/09/2007CA2246842C Reagent for evaluating a hepatic operation
01/09/2007CA2236578C Dopamine transporter imaging agent
01/09/2007CA2201620C Diagnostic and diagnosis method for central nervous abnormality and phenylketonuria
01/09/2007CA2162732C Use of modified tall-104 cells to treat cancer and viral diseases
01/04/2007WO2007002540A2 Radiolabeled-pegylation of ligands for use as imaging agents
01/04/2007WO2007002500A1 Gastrin releasing peptide compounds
01/04/2007WO2007001958A2 Stereoselective synthesis of amino acid analogs for tumor imaging
01/04/2007WO2007001940A2 Imaging agents
01/04/2007WO2007001466A2 Peptidomimetic somatostatin receptor subtype 2 ligands and pet imaging agents
01/04/2007WO2007001459A2 Compositions and methods for modulating lymphocyte activity
01/04/2007WO2007000145A2 Analysis method for determining a functional parameter of an organ using preferably an aqueous 13c methacetin solution
01/04/2007WO2006116629A3 The preparation of molecular imaging probes using click chemistry
01/04/2007WO2006103509A3 Methods for carbon isotope labeling synthesis by transition metal-promoted carbonylation via ketene using diazo compounds and carbon-isotope monoxide
01/04/2007WO2006093911A3 Thiazolylmethyl and oxazolylmethyl heteroaryl derivatives
01/04/2007WO2006043083A3 Liposomes enclosing a radionuclide and a cytotoxic agent for combination therapy
01/04/2007US20070003480 Liposomal composition comprising haptotactic peptides
01/04/2007US20070003479 Diagnostic imaging contrast agents with extended blood retention
01/04/2007CA2617319A1 Radiolabeled-pegylation of ligands for use as imaging agents
01/04/2007CA2613317A1 Analysis method for determining a functional parameter of an organ using preferably an aqueous 13c methacetin solution
01/04/2007CA2612486A1 Anti-cd71 monoclonal antibodies and uses thereof for treating malignant tumour cells
01/04/2007CA2612187A1 Stereoselective synthesis of amino acid analogs for tumor imaging
01/04/2007CA2612186A1 Imaging agents
01/03/2007EP1737500A1 Bioresponsive polymer system for delivery of microbicides
01/03/2007EP1476467B9 Immunoglobulin igg3 as a marker for protecting against infectious viral diseases, and the uses of the same
01/03/2007EP1173765B1 Diagnostic and therapeutic use of antibodies against the urokinase receptor
01/03/2007EP0942996B1 Thrombolytic agents with antithrombotic activity
01/03/2007CN1887829A Synthesis process of 18F lebeled positive electron radioactive tracer with ionic liquid as phase transfer catalyst
01/03/2007CN1293051C Diaminedithiol derivatives and radiorhenium or radoitechnetium complex thereof; liver cancer-treating composition comprising radiorhenium complex and lipiodol; and kit for preparation of liver cancer
01/03/2007CN1292798C Ethylenedicysteine (EC)-drug conjugates
01/02/2007USRE39456 Radioactive embolizing compositions
01/02/2007US7157554 Forming a carboxy-saccharide derivative of the glycopeptide antibiotic that has a substituent containing a dicarboxylic acid in which one of the carboxylic acid groups is coupled with a saccharide
01/02/2007US7157238 Identifying micrometastsized tissue/masses using double immunoglobulin labeling; immunodiagnostics and cancer detection
01/02/2007US7157098 A cationic lipid dipalmitoyl-sn-glycero-ethylphosphocholine (DPEP) or dilauroyl-sn-glycero-ethylphosphocholine (DLEP) and dioleoylphosphatidylethanolamine (DOPE); a plasmid cDNA sequence encoding a protein having anticarcinogenic and antiapoptosis activity; delivery of DNA to the respiratory tract
01/02/2007CA2275451C Radioactive technetium and rhenium nitride heterocomplexes
12/2006
12/28/2006WO2006137886A2 Assay for vitamin b12 absorption and method of making labeled vitamin b12
12/28/2006WO2006136564A1 Multidentate aza ligands able to complex metal ions and the use thereof in diagnostics and therapy
12/28/2006WO2006105234A3 Hybrid inorganic nanoparticles, methods of using and methods of making
12/28/2006WO2006104417A3 Substance and method for treating neoplasms
12/28/2006WO2004041067A3 Prevention and treatment of synucleinopathic disease
12/28/2006US20060292660 Drug screening; administering albumin attached to alcohol, organic acid, saccharide or amino acid and determining amount administered to the subject or degradation product or metabolite that migrated into the blood and/or is excreted out of the body
12/28/2006US20060292643 Recognition molecules for the treatment and detection of tumours
12/28/2006US20060292075 Labelled glutamine and lysine analogues
12/28/2006US20060292074 Tomoregulin antibodies and uses thereof
12/28/2006US20060292073 Stereoselective Synthesis of Amino Acid Analogs for Tumor Imaging